PMID: 25033378

LaRusch J, Jung J, General IJ, Lewis MD, Park HW, Brand RE, Gelrud A, Anderson MA, Banks PA, Conwell D, Lawrence C, Romagnuolo J, Baillie J, Alkaade S, Cote G, Gardner TB, Amann ST, Slivka A, Sandhu B, Aloe A, Kienholz ML, Yadav D, Barmada MM, Bahar I, Lee MG, Whitcomb DC
Mechanisms of CFTR functional variants that impair regulated bicarbonate permeation and increase risk for pancreatitis but not for cystic fibrosis.
PLoS Genet. 2014 Jul 17;10(7):e1004376. doi: 10.1371/journal.pgen.1004376. eCollection 2014 Jul., [PubMed]
Sentences
No. Mutations Sentence Comment
5 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 25033378:5:32
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Asp1270Asn
X
ABCC7 p.Asp1270Asn 25033378:5:80
status: NEW
view ABCC7 p.Asp1270Asn details
ABCC7 p.Arg75Gln
X
ABCC7 p.Arg75Gln 25033378:5:26
status: NEW
view ABCC7 p.Arg75Gln details
ABCC7 p.Ser1235Arg
X
ABCC7 p.Ser1235Arg 25033378:5:68
status: NEW
view ABCC7 p.Ser1235Arg details
ABCC7 p.Asp1152His
X
ABCC7 p.Asp1152His 25033378:5:60
status: NEW
view ABCC7 p.Asp1152His details
ABCC7 p.Leu997Phe
X
ABCC7 p.Leu997Phe 25033378:5:53
status: NEW
view ABCC7 p.Leu997Phe details
ABCC7 p.Arg170His
X
ABCC7 p.Arg170His 25033378:5:39
status: NEW
view ABCC7 p.Arg170His details
ABCC7 p.Leu967Ser
X
ABCC7 p.Leu967Ser 25033378:5:46
status: NEW
view ABCC7 p.Leu967Ser details
ABCC7 p.Arg74Gln
X
ABCC7 p.Arg74Gln 25033378:5:20
status: NEW
view ABCC7 p.Arg74Gln details
Nine variants (CFTR R74Q, R75Q, R117H, R170H, L967S, L997F, D1152H, S1235R, and D1270N) not associated with typical CF were associated with pancreatitis (OR 1.5, p = 0.002). Login to comment
39 ABCC7 p.Arg75Gln
X
ABCC7 p.Arg75Gln 25033378:39:44
status: NEW
view ABCC7 p.Arg75Gln details
Recently, we reported that the variant CFTR R75Q, which was previously classified as benign, is associated with familial and sporadic chronic pancreatitis, either with another CFTR variant (recessive) or with the serine protease inhibitor, Kazal Type 1 (SPINK1) N34S high-risk haplotype (complex genotype)[18]. Login to comment
40 ABCC7 p.Arg75Gln
X
ABCC7 p.Arg75Gln 25033378:40:28
status: NEW
view ABCC7 p.Arg75Gln details
Patch-clamp studies of CFTR R75Q clones under standard conditions demonstrated normal chloride conductance but a selective disruption in bicarbonate conductance[18]. Login to comment
41 ABCC7 p.Arg75Gln
X
ABCC7 p.Arg75Gln 25033378:41:11
status: NEW
view ABCC7 p.Arg75Gln details
Thus, CFTR R75Q causes selective bicarbonate defective (CFTRBD ) conductance and is associated with chronic pancreatitis but not CF[18]. Login to comment
62 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 25033378:62:189
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Asp1270Asn
X
ABCC7 p.Asp1270Asn 25033378:62:291
status: NEW
view ABCC7 p.Asp1270Asn details
ABCC7 p.Arg75Gln
X
ABCC7 p.Arg75Gln 25033378:62:183
status: NEW
view ABCC7 p.Arg75Gln details
ABCC7 p.Ser1235Arg
X
ABCC7 p.Ser1235Arg 25033378:62:279
status: NEW
view ABCC7 p.Ser1235Arg details
ABCC7 p.Asp1152His
X
ABCC7 p.Asp1152His 25033378:62:271
status: NEW
view ABCC7 p.Asp1152His details
ABCC7 p.Leu997Phe
X
ABCC7 p.Leu997Phe 25033378:62:264
status: NEW
view ABCC7 p.Leu997Phe details
ABCC7 p.Arg170His
X
ABCC7 p.Arg170His 25033378:62:250
status: NEW
view ABCC7 p.Arg170His details
ABCC7 p.Leu967Ser
X
ABCC7 p.Leu967Ser 25033378:62:257
status: NEW
view ABCC7 p.Leu967Ser details
ABCC7 p.Arg74Gln
X
ABCC7 p.Arg74Gln 25033378:62:177
status: NEW
view ABCC7 p.Arg74Gln details
Of 43 CFTR variants identified in the NAPS2 cohort (Table 1), nine not associated with typical CF but reported in patients with pancreatitis[25-29] were of particular interest: R74Q, R75Q, R117H (CFTRm-v only when in cis with IVS8-T5[30]; R117H*T5), R170H, L967S, L997F, D1152H, S1235R, and D1270N. Login to comment
66 ABCC7 p.Ile148Thr
X
ABCC7 p.Ile148Thr 25033378:66:41
status: NEW
view ABCC7 p.Ile148Thr details
Other candidate CFTR variants, including I148T, M470V, T854T, Q1463Q and the ''5T`` allele, were either rare or were not associated with pancreatitis in our cohort (Table 1). Login to comment
71 ABCC7 p.Ile148Thr
X
ABCC7 p.Ile148Thr 25033378:71:0
status: NEW
view ABCC7 p.Ile148Thr details
ABCC7 p.Ile148Thr
X
ABCC7 p.Ile148Thr 25033378:71:157
status: NEW
view ABCC7 p.Ile148Thr details
I148T was seen in three cases and one control, so an effect could not be detected or excluded; the in cis deletion mutation 3199del6 was not detected in any I148T carriers. Login to comment
72 ABCC7 p.Arg1162*
X
ABCC7 p.Arg1162* 25033378:72:387
status: NEW
view ABCC7 p.Arg1162* details
ABCC7 p.Gly1069Arg
X
ABCC7 p.Gly1069Arg 25033378:72:441
status: NEW
view ABCC7 p.Gly1069Arg details
The IVS8T5 variant was identified in 9.9% of cases and 8.2% of controls, which is not individually significant. There were six N34S/T5 trans-heterozygote controls and no cases, but the combined effect of the SPINK1 N34S variant with IVS8T5 was not significantly higher than N34S alone. Four variants were identified in only one patient and no controls: CF mutations 2184delA, 3120+1G.A, R1162X, and mutation of varying clinical consequence, G1069R. Login to comment
73 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 25033378:73:210
status: NEW
view ABCC7 p.Arg117His details
Functional assays on CFTR variants For our functional studies, we cloned the nine CFTR variants and confirmed that they had normal folding, glycosylation (Figure 1a) and chloride channel activities, except for R117H (Figure 1b). Login to comment
78 ABCC7 p.Arg170His
X
ABCC7 p.Arg170His 25033378:78:55
status: NEW
view ABCC7 p.Arg170His details
In contrast, CFTR PHCO3/PCl failed to increase in CFTR R170H (Figure 1d) and all of the candidate CFTRBD variants (Figures 1e and S2). Login to comment
79 ABCC7 p.Asp1270Asn
X
ABCC7 p.Asp1270Asn 25033378:79:265
status: NEW
view ABCC7 p.Asp1270Asn details
Furthermore, all CFTRBD candidate variants lowered bicarbonate conductance (GHCO3/ GCl), which is an important metric determining apical bicarbonate efflux in CFTR-expressing epithelia (Figure 1f); the decrease was statistically significant for all variants except D1270N. Login to comment
95 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 25033378:95:459
status: NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 25033378:95:765
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 25033378:95:500
status: NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Asn1303Lys
X
ABCC7 p.Asn1303Lys 25033378:95:335
status: NEW
view ABCC7 p.Asn1303Lys details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 25033378:95:542
status: NEW
view ABCC7 p.Gly542* details
ABCC7 p.Arg1162*
X
ABCC7 p.Arg1162* 25033378:95:569
status: NEW
view ABCC7 p.Arg1162* details
ABCC7 p.Asp1270Asn
X
ABCC7 p.Asp1270Asn 25033378:95:926
status: NEW
view ABCC7 p.Asp1270Asn details
ABCC7 p.Arg75Gln
X
ABCC7 p.Arg75Gln 25033378:95:680
status: NEW
view ABCC7 p.Arg75Gln details
ABCC7 p.Ser1235Arg
X
ABCC7 p.Ser1235Arg 25033378:95:722
status: NEW
view ABCC7 p.Ser1235Arg details
ABCC7 p.Asp1152His
X
ABCC7 p.Asp1152His 25033378:95:898
status: NEW
view ABCC7 p.Asp1152His details
ABCC7 p.Arg668Cys
X
ABCC7 p.Arg668Cys 25033378:95:1336
status: NEW
view ABCC7 p.Arg668Cys details
ABCC7 p.Gly576Ala
X
ABCC7 p.Gly576Ala 25033378:95:1374
status: NEW
view ABCC7 p.Gly576Ala details
ABCC7 p.Leu997Phe
X
ABCC7 p.Leu997Phe 25033378:95:857
status: NEW
view ABCC7 p.Leu997Phe details
ABCC7 p.Arg170His
X
ABCC7 p.Arg170His 25033378:95:968
status: NEW
view ABCC7 p.Arg170His details
ABCC7 p.Leu967Ser
X
ABCC7 p.Leu967Ser 25033378:95:813
status: NEW
view ABCC7 p.Leu967Ser details
ABCC7 p.Arg74Gln
X
ABCC7 p.Arg74Gln 25033378:95:995
status: NEW
view ABCC7 p.Arg74Gln details
CFTR variant %Cases %Uctrls OR p-value %Cases w/N34S OR w/N34S p-value w/N34S CF/BD or BD/BD 2.5 0.1 31.9 ,0.0001 5.5 7.46 0.12 All CF 8.7 3.3 2.76 ,0.0001 16.4 5.65 ,0.0001 F508del CF 6.9 3.1 2.32 ,0.0001 14.5 5.13 ,0.0001 IVS8T5** CF 9.9 8.2 1.24 0.079 10.9 1.37 0.47 2789+5G.A CF 0.3 0.0 0.028 0.0 3849+10kbC.T CF 0.3 0.0 0.028 0.0 N1303K CF 0.3 0.0 0.027 0.0 621+1G.T CF 0.1 0.0 0.13 1.8 ,0.0001 2184delA CF 0.1 0.0 0.13 0.0 3120+1G.A CF 0.1 0.0 0.13 0.0 G551D CF 0.2 0.1 2.50 0.20 0.0 0.00 0.83 W1282X CF 0.2 0.1 2.50 0.20 0.0 0.00 0.83 G542X CF 0.2 0.0 0.059 0.0 R1162X CF 0.1 0.0 0.13 0.0 2183AA.G CF 0.0 0.1 0.17 0.0 0.00 0.83 All BD 14.2 9.8 1.50 0.002 25.5 4.63 ,0.0001 R75Q BD 6.3 6.2 1.02 0.30 16.4 2.97 0.003 S1235R BD 2.4 1.4 1.69 0.052 1.8 1.30 0.80 R117H CF/BD 2.3 0.7 3.49 0.0007 5.5 8.74 0.0002 L967S BD 1.1 0.2 6.87 0.002 1.8 11.17 0.014 L997F BD 0.8 1.0 0.82 0.26 1.8 1.84 0.55 D1152H BD 0.4 0.0 0.014 0.0 D1270N BD 0.3 0.2 1.25 0.29 0.0 0.00 0.71 R170H BD 0.3 0.0 0.028 0.0 R74Q BD 0.3 0.1 3.02 0.17 1.8 21.15 0.002 Other M470V 76.1 74.2 1.11 0.14 70.9 0.85 0.59 T854T 57.3 57.8 0.98 0.29 45.5 0.61 0.071 Q1463Q 39.6 39.5 1.01 0.30 40.0 1.02 0.94 1001+11C.T* 13.4 10.9 1.27 0.016 14.5 1.40 0.42 125G.C 10.3 9.7 1.07 0.26 12.7 1.36 0.45 P1290P 7.6 7.9 0.95 0.28 7.3 0.91 0.86 1716G.A 4.5 4.1 1.10 0.26 1.8 0.43 0.39 R668C 1.0 1.4 0.72 0.19 0.0 0.00 0.38 G576A 0.7 1.2 0.58 0.11 0.0 0.00 0.41 computationally modeled the molecular structure, and studied the dynamics, of wild type (WT) and mutated CFTR channels. Login to comment
102 ABCC7 p.Asp1152His
X
ABCC7 p.Asp1152His 25033378:102:79
status: NEW
view ABCC7 p.Asp1152His details
ABCC7 p.Asp1152His
X
ABCC7 p.Asp1152His 25033378:102:426
status: NEW
view ABCC7 p.Asp1152His details
ABCC7 p.Leu997Phe
X
ABCC7 p.Leu997Phe 25033378:102:69
status: NEW
view ABCC7 p.Leu997Phe details
ABCC7 p.Leu997Phe
X
ABCC7 p.Leu997Phe 25033378:102:289
status: NEW
view ABCC7 p.Leu997Phe details
MD simulations comparing the channel diameters of the WT and mutants L997F and D1152H (Figure 2c-f) demonstrate that the channel diameter is observed to narrow down from an average value of 10.3 A da; to 7.5 A da; (standard deviation, s = 0.5 A da; ) at the pore region, near the L997F amino acid substitution (Figure 2e), and from an average of 9.9 A da; to 4.3 A da; (s = 1.1 A da; ) for the CFTRBD mutant D1152H (Figure 2f). Login to comment
103 ABCC7 p.Asp1152His
X
ABCC7 p.Asp1152His 25033378:103:103
status: NEW
view ABCC7 p.Asp1152His details
ABCC7 p.Leu997Phe
X
ABCC7 p.Leu997Phe 25033378:103:41
status: NEW
view ABCC7 p.Leu997Phe details
Note that in contrast to the WT CFTR and L997F mutant where the structure maintains its stability, the D1152H mutation induces significant fluctuations in local conformation, which are reflected on the changes in the pore diameter at this location within the channel. Login to comment
116 ABCC7 p.Arg74Trp
X
ABCC7 p.Arg74Trp 25033378:116:308
status: NEW
view ABCC7 p.Arg74Trp details
ABCC7 p.Ile148Thr
X
ABCC7 p.Ile148Thr 25033378:116:232
status: NEW
view ABCC7 p.Ile148Thr details
ABCC7 p.Arg258Gly
X
ABCC7 p.Arg258Gly 25033378:116:422
status: NEW
view ABCC7 p.Arg258Gly details
ABCC7 p.Phe1052Val
X
ABCC7 p.Phe1052Val 25033378:116:345
status: NEW
view ABCC7 p.Phe1052Val details
ABCC7 p.Phe508Cys
X
ABCC7 p.Phe508Cys 25033378:116:78
status: NEW
view ABCC7 p.Phe508Cys details
ABCC7 p.Arg31Cys
X
ABCC7 p.Arg31Cys 25033378:116:194
status: NEW
view ABCC7 p.Arg31Cys details
ABCC7 p.Arg297Gln
X
ABCC7 p.Arg297Gln 25033378:116:270
status: NEW
view ABCC7 p.Arg297Gln details
ABCC7 p.Ile1027Thr
X
ABCC7 p.Ile1027Thr 25033378:116:155
status: NEW
view ABCC7 p.Ile1027Thr details
ABCC7 p.Arg1162Leu
X
ABCC7 p.Arg1162Leu 25033378:116:116
status: NEW
view ABCC7 p.Arg1162Leu details
ABCC7 p.Val201Met
X
ABCC7 p.Val201Met 25033378:116:484
status: NEW
view ABCC7 p.Val201Met details
ABCC7 p.Gly1069Arg
X
ABCC7 p.Gly1069Arg 25033378:116:460
status: NEW
view ABCC7 p.Gly1069Arg details
ABCC7 p.Ile807Met
X
ABCC7 p.Ile807Met 25033378:116:384
status: NEW
view ABCC7 p.Ile807Met details
CFTR variant %Cases %Uctrls OR p-value %Cases w/N34S OR w/N34S p-value w/N34S F508C 0.5 0.3 1.58 0.21 0.0 0.00 0.67 R1162L 0.5 0.5 1.13 0.29 1.8 4.03 0.17 I1027T 0.5 0.3 1.99 0.17 0.0 0.00 0.70 R31C 0.3 0.7 0.42 0.088 0.0 0.00 0.52 I148T 0.3 0.4 0.75 0.27 0.0 0.00 0.63 R297Q 0.3 0.2 1.89 0.21 0.0 0.00 0.76 R74W 0.2 0.2 0.85 0.29 0.0 0.00 0.71 F1052V 0.1 0.2 0.63 0.27 0.0 0.00 0.76 I807M 0.1 0.1 1.26 0.30 0.0 0.00 0.83 R258G 0.1 0.1 1.26 0.30 0.0 0.00 0.83 G1069R 0.1 0.0 0.13 0.0 V201M 0.0 0.1 0.17 0.0 0.00 0.83 Of the 81 CFTR mutations tested in the cohort, 43 were observed at least once in cases or controls. Login to comment
119 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 25033378:119:107
status: NEW
view ABCC7 p.Arg117His details
Blank cells indicate undefined (e.g. x40) **IVS8 T5 is reported but causes CF only when in cis with either R117H or IVS8 TG12or13. Intronic mutations are reported in standard nomenclature ''####+/2##N.N`` except IVS8-T5 (1210-12T[5]). Login to comment
124 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 25033378:124:24
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 25033378:124:135
status: NEW
view ABCC7 p.Gly542* details
ABCC7 p.Arg75Gln
X
ABCC7 p.Arg75Gln 25033378:124:18
status: NEW
view ABCC7 p.Arg75Gln details
ABCC7 p.Ser1235Arg
X
ABCC7 p.Ser1235Arg 25033378:124:57
status: NEW
view ABCC7 p.Ser1235Arg details
ABCC7 p.Asp1152His
X
ABCC7 p.Asp1152His 25033378:124:45
status: NEW
view ABCC7 p.Asp1152His details
ABCC7 p.Leu997Phe
X
ABCC7 p.Leu997Phe 25033378:124:38
status: NEW
view ABCC7 p.Leu997Phe details
ABCC7 p.Leu967Ser
X
ABCC7 p.Leu967Ser 25033378:124:31
status: NEW
view ABCC7 p.Leu967Ser details
We identified the R75Q, R117H, L967S, L997F, D1152H, and S1235R CFTRBD variants as well as CFTRCF -associated variants (e.g., F508del, G542X) in cases with rhinosinusitis. Login to comment
129 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 25033378:129:20
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 25033378:129:78
status: NEW
view ABCC7 p.Gly542* details
ABCC7 p.Arg75Gln
X
ABCC7 p.Arg75Gln 25033378:129:14
status: NEW
view ABCC7 p.Arg75Gln details
ABCC7 p.Ser1235Arg
X
ABCC7 p.Ser1235Arg 25033378:129:31
status: NEW
view ABCC7 p.Ser1235Arg details
We identified R75Q, R117H, and S1235R as well as the CFTRCF variants F508del, G542X and 2789+5G,A in male cases with infertility. Login to comment
158 ABCC7 p.Arg170His
X
ABCC7 p.Arg170His 25033378:158:23
status: NEW
view ABCC7 p.Arg170His details
Whole-cell currents of R170H-CFTR were measured in HEK 293T cells using the same protocol shown in panel c. Login to comment
170 ABCC7 p.Arg75Gln
X
ABCC7 p.Arg75Gln 25033378:170:21
status: NEW
view ABCC7 p.Arg75Gln details
ABCC7 p.Arg1162Leu
X
ABCC7 p.Arg1162Leu 25033378:170:45
status: NEW
view ABCC7 p.Arg1162Leu details
ABCC7 p.Arg170His
X
ABCC7 p.Arg170His 25033378:170:27
status: NEW
view ABCC7 p.Arg170His details
ABCC7 p.Leu967Ser
X
ABCC7 p.Leu967Ser 25033378:170:34
status: NEW
view ABCC7 p.Leu967Ser details
ABCC7 p.Arg74Gln
X
ABCC7 p.Arg74Gln 25033378:170:15
status: NEW
view ABCC7 p.Arg74Gln details
Five variants (R74Q, R75Q, R170H, L967S, and R1162L) were located in the hinge region that modulates the collective movements of the NBDs with respect to the MSDs (Figure 3). Login to comment
171 ABCC7 p.Arg74Gln
X
ABCC7 p.Arg74Gln 25033378:171:0
status: NEW
view ABCC7 p.Arg74Gln details
ABCC7 p.Arg74Gln
X
ABCC7 p.Arg74Gln 25033378:171:111
status: NEW
view ABCC7 p.Arg74Gln details
R74Q was previously reported in a single chronic pancreatitis patient [53] but not in the CFTR2 database. CFTR R74Q was identified by us in two cases and no controls (p = ns) and in one case who was a SPINK1 N34S carrier (p = 0.006). Login to comment
172 ABCC7 p.Arg75Gln
X
ABCC7 p.Arg75Gln 25033378:172:0
status: NEW
view ABCC7 p.Arg75Gln details
R75Q is considered to be a non-CF causing mutation according to the CFTR2 mutation database [54]. Login to comment
173 ABCC7 p.Arg75Gln
X
ABCC7 p.Arg75Gln 25033378:173:5
status: NEW
view ABCC7 p.Arg75Gln details
ABCC7 p.Arg75Gln
X
ABCC7 p.Arg75Gln 25033378:173:214
status: NEW
view ABCC7 p.Arg75Gln details
CFTR R75Q was identified in 61/906 cases and 75/1214 controls (6.3 vs. 6.2%, p = ns) but was also detected in nine SPINK1 N34S/- mutation carriers (9/55, 16.4%), with strong combined effect (SPINK1 OR 3.7, SPINK1+ R75Q compound OR 12.2, p 0.002). Login to comment
175 ABCC7 p.Arg75Gln
X
ABCC7 p.Arg75Gln 25033378:175:0
status: NEW
view ABCC7 p.Arg75Gln details
R75Q was also identified in four cases with a concurrent severe CF-causing mutation and in no compound controls. Login to comment
176 ABCC7 p.Arg170His
X
ABCC7 p.Arg170His 25033378:176:0
status: NEW
view ABCC7 p.Arg170His details
R170H was first reported Figure 3. Login to comment
188 ABCC7 p.Asp1152His
X
ABCC7 p.Asp1152His 25033378:188:45
status: NEW
view ABCC7 p.Asp1152His details
Panel c shows the charge distribution around D1152H: this negatively charged residue (left; shown in red space-filling representation) is surrounded by several positively charged residues (green), especially on its side of the cavity, creating an attractive force that keeps the residue from extending into the cavity. Login to comment
190 ABCC7 p.Asp1152His
X
ABCC7 p.Asp1152His 25033378:190:63
status: NEW
view ABCC7 p.Asp1152His details
Panel d shows the corresponding scene for the variant residue, D1152H (cyan), which can move toward the center of the cavity, thus leading to a constriction in the channel diameter. Login to comment
192 ABCC7 p.Asp1152His
X
ABCC7 p.Asp1152His 25033378:192:56
status: NEW
view ABCC7 p.Asp1152His details
On panel f, the same information for the WT and variant D1152H is shown. Login to comment
195 ABCC7 p.Arg170His
X
ABCC7 p.Arg170His 25033378:195:174
status: NEW
view ABCC7 p.Arg170His details
doi:10.1371/journal.pgen.1004376.g002 in two cases of congenital bilateral aplasia of vas deferens in England [53] but is not currently in the CFTR2 mutation database. CFTR R170H was identified in three cases and no controls (p = ns). Login to comment
196 ABCC7 p.Leu967Ser
X
ABCC7 p.Leu967Ser 25033378:196:0
status: NEW
view ABCC7 p.Leu967Ser details
L967S has been reported in a single case of azoospermia from the CF mutation database [53] but is not in the CFTR2 mutation database. Login to comment
197 ABCC7 p.Leu967Ser
X
ABCC7 p.Leu967Ser 25033378:197:0
status: NEW
view ABCC7 p.Leu967Ser details
L967S was identified in ten cases (one trans-heterozygote), two controls (OR 6.9 p = 0.004), and one N34S case carrier. Login to comment
198 ABCC7 p.Arg1162Leu
X
ABCC7 p.Arg1162Leu 25033378:198:0
status: NEW
view ABCC7 p.Arg1162Leu details
R1162L is predicted to be a highly deleterious variant by SIFT and damaging by PolyPhen modeling [55] and is included in the CFTR2 mutation database and classified as a variant not causing CF. Login to comment
199 ABCC7 p.Asp1152His
X
ABCC7 p.Asp1152His 25033378:199:180
status: NEW
view ABCC7 p.Asp1152His details
ABCC7 p.Leu997Phe
X
ABCC7 p.Leu997Phe 25033378:199:170
status: NEW
view ABCC7 p.Leu997Phe details
Although located in a critical portion of the CFTR molecule, the association and functional threshold for inclusion as a CFTRBD variant were not fully met. Two variants (L997F and D1152H) appeared to reduce channel diameter. Login to comment
200 ABCC7 p.Leu997Phe
X
ABCC7 p.Leu997Phe 25033378:200:0
status: NEW
view ABCC7 p.Leu997Phe details
L997F is considered a mutation of varying clinical consequences for CF, with low rates of pancreatic insufficiency and retention of chloride conductance [54]. Login to comment
201 ABCC7 p.Leu997Phe
X
ABCC7 p.Leu997Phe 25033378:201:14
status: NEW
view ABCC7 p.Leu997Phe details
ABCC7 p.Leu997Phe
X
ABCC7 p.Leu997Phe 25033378:201:95
status: NEW
view ABCC7 p.Leu997Phe details
In this study L997F was identified both in the cases (0.7%) and controls (1.0%), additionally, L997F was identified in one N34S case carrier and three compound heterozygous mutation case carriers, but independent statistical association with pancreatitis was not demonstrated in this study. Login to comment
202 ABCC7 p.Asp1152His
X
ABCC7 p.Asp1152His 25033378:202:0
status: NEW
view ABCC7 p.Asp1152His details
D1152H is a mutation of varying clinical consequence for CF and is associated with low rates of pancreatic insufficiency and retention of chloride conductance [53]. Login to comment
203 ABCC7 p.Asp1152His
X
ABCC7 p.Asp1152His 25033378:203:5
status: NEW
view ABCC7 p.Asp1152His details
CFTR D1152H was identified in four cases and no controls (p = 0.014). Login to comment
205 ABCC7 p.Asp1270Asn
X
ABCC7 p.Asp1270Asn 25033378:205:24
status: NEW
view ABCC7 p.Asp1270Asn details
Two variants (S1235 and D1270N) were on the surface of NBD2 (Figure 2). Login to comment
207 ABCC7 p.Ser1235Arg
X
ABCC7 p.Ser1235Arg 25033378:207:100
status: NEW
view ABCC7 p.Ser1235Arg details
While this did not reach statistical significance in this cohort, multiple previous reports of CFTR S1235R in idiopathic pancreatitis patients[56,57] and complex functional features [27] were noted. Login to comment
208 ABCC7 p.Asp1270Asn
X
ABCC7 p.Asp1270Asn 25033378:208:0
status: NEW
view ABCC7 p.Asp1270Asn details
D1270N is of varying clinical consequences for CF, with low rates of pancreatic insufficiency and retention of chloride conductance [54]. Login to comment
209 ABCC7 p.Asp1270Asn
X
ABCC7 p.Asp1270Asn 25033378:209:0
status: NEW
view ABCC7 p.Asp1270Asn details
D1270N was identified both in the cases (0.3%) and controls (0.2%). Login to comment
212 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 25033378:212:19
status: NEW
view ABCC7 p.Arg117His details
The final variant (R117H) is located in an extracellular domain and has functional effects beyond the other CFTRBD variants. Login to comment
213 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 25033378:213:0
status: NEW
view ABCC7 p.Arg117His details
R117H is a complex variant that is associated with CF only when found in cis with a T5 tract in intron 8. Login to comment
214 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 25033378:214:9
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 25033378:214:207
status: NEW
view ABCC7 p.Arg117His details
The CFTR R117H variant was identified in 22 cases (2.3%) and 8 controls (0.7%) (p = 0.001), with only 3 cases and 1 control having the CF-associated R117H*T5 haplotype (p = ns), which links the CFTR variant R117H to pancreatitis regardless of the intron 8 T5 haplotype. Login to comment
216 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 25033378:216:4
status: NEW
view ABCC7 p.Arg117His details
The R117H variant was the only one with reduced chloride current density (Figure 1b). Login to comment
224 ABCC7 p.Ile148Thr
X
ABCC7 p.Ile148Thr 25033378:224:0
status: NEW
view ABCC7 p.Ile148Thr details
ABCC7 p.Ile148Thr
X
ABCC7 p.Ile148Thr 25033378:224:157
status: NEW
view ABCC7 p.Ile148Thr details
I148T was seen in three cases and one control, so an effect could not be detected or excluded; the in cis deletion mutation 3199del6 was not detected in any I148T carriers. Login to comment
225 ABCC7 p.Arg1162*
X
ABCC7 p.Arg1162* 25033378:225:411
status: NEW
view ABCC7 p.Arg1162* details
ABCC7 p.Gly1069Arg
X
ABCC7 p.Gly1069Arg 25033378:225:466
status: NEW
view ABCC7 p.Gly1069Arg details
The IVS8T5 variant was identified in 9.9% of cases and 8.2% of controls, which is not individually significant. There were six N34S/T5 trans-heterozygote controls and no cases, but the combined odds ratio (OR 3.9) of the SPINK1 N34S variant with IVS8T5 was not significantly higher than N34S alone. Four additional variants were identified in only one patient and no controls: CF mutations 2184delA, 3120+1G.A, R1162X and a mutation of varying clinical consequence, G1069R. Login to comment
228 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 25033378:228:157
status: NEW
view ABCC7 p.Arg117His details
In addition, other possible mechanisms of CFTR channel dysfunction linked to altered bicarbonate conductance are possible, such as mechanisms linked to CFTR R117H. Login to comment
237 ABCC7 p.Asp1152His
X
ABCC7 p.Asp1152His 25033378:237:29
status: NEW
view ABCC7 p.Asp1152His details
ABCC7 p.Leu997Phe
X
ABCC7 p.Leu997Phe 25033378:237:19
status: NEW
view ABCC7 p.Leu997Phe details
In particular, the L997F and D1152H mutants showed channel pore size reductions in their neighborhoods that would directly affect conductance properties. Login to comment
248 ABCC7 p.Leu997Phe
X
ABCC7 p.Leu997Phe 25033378:248:50
status: NEW
view ABCC7 p.Leu997Phe details
A decrease in the CFTR pore diameter, as shown in L997F, can affect the permeability of HCO3 2 in many ways, such as by limiting the accessibility of large, asymmetrically charged HCO3 2 to the channel pore. Login to comment
269 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 25033378:269:250
status: NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 25033378:269:415
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 25033378:269:136
status: NEW
view ABCC7 p.Ala455Glu details
ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 25033378:269:533
status: NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Arg553*
X
ABCC7 p.Arg553* 25033378:269:456
status: NEW
view ABCC7 p.Arg553* details
ABCC7 p.Gly551Ser
X
ABCC7 p.Gly551Ser 25033378:269:257
status: NEW
view ABCC7 p.Gly551Ser details
ABCC7 p.Gly1244Glu
X
ABCC7 p.Gly1244Glu 25033378:269:220
status: NEW
view ABCC7 p.Gly1244Glu details
ABCC7 p.Gly1349Asp
X
ABCC7 p.Gly1349Asp 25033378:269:228
status: NEW
view ABCC7 p.Gly1349Asp details
ABCC7 p.Ser1255Pro
X
ABCC7 p.Ser1255Pro 25033378:269:490
status: NEW
view ABCC7 p.Ser1255Pro details
ABCC7 p.Arg334Trp
X
ABCC7 p.Arg334Trp 25033378:269:630
status: NEW
view ABCC7 p.Arg334Trp details
ABCC7 p.Arg347Pro
X
ABCC7 p.Arg347Pro 25033378:269:637
status: NEW
view ABCC7 p.Arg347Pro details
ABCC7 p.Asn1303Lys
X
ABCC7 p.Asn1303Lys 25033378:269:370
status: NEW
view ABCC7 p.Asn1303Lys details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 25033378:269:243
status: NEW
view ABCC7 p.Gly542* details
ABCC7 p.Arg1162*
X
ABCC7 p.Arg1162* 25033378:269:400
status: NEW
view ABCC7 p.Arg1162* details
ABCC7 p.Asp1270Asn
X
ABCC7 p.Asp1270Asn 25033378:269:158
status: NEW
view ABCC7 p.Asp1270Asn details
ABCC7 p.Arg74Trp
X
ABCC7 p.Arg74Trp 25033378:269:470
status: NEW
view ABCC7 p.Arg74Trp details
ABCC7 p.Arg352Gln
X
ABCC7 p.Arg352Gln 25033378:269:449
status: NEW
view ABCC7 p.Arg352Gln details
ABCC7 p.Ile148Thr
X
ABCC7 p.Ile148Thr 25033378:269:274
status: NEW
view ABCC7 p.Ile148Thr details
ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 25033378:269:616
status: NEW
view ABCC7 p.Gly85Glu details
ABCC7 p.Arg560Thr
X
ABCC7 p.Arg560Thr 25033378:269:601
status: NEW
view ABCC7 p.Arg560Thr details
ABCC7 p.Arg75Gln
X
ABCC7 p.Arg75Gln 25033378:269:476
status: NEW
view ABCC7 p.Arg75Gln details
ABCC7 p.Pro67Leu
X
ABCC7 p.Pro67Leu 25033378:269:378
status: NEW
view ABCC7 p.Pro67Leu details
ABCC7 p.Met952Thr
X
ABCC7 p.Met952Thr 25033378:269:363
status: NEW
view ABCC7 p.Met952Thr details
ABCC7 p.Arg258Gly
X
ABCC7 p.Arg258Gly 25033378:269:429
status: NEW
view ABCC7 p.Arg258Gly details
ABCC7 p.Thr338Ile
X
ABCC7 p.Thr338Ile 25033378:269:512
status: NEW
view ABCC7 p.Thr338Ile details
ABCC7 p.Leu1065Pro
X
ABCC7 p.Leu1065Pro 25033378:269:322
status: NEW
view ABCC7 p.Leu1065Pro details
ABCC7 p.Arg1070Gln
X
ABCC7 p.Arg1070Gln 25033378:269:392
status: NEW
view ABCC7 p.Arg1070Gln details
ABCC7 p.Ser1235Arg
X
ABCC7 p.Ser1235Arg 25033378:269:482
status: NEW
view ABCC7 p.Ser1235Arg details
ABCC7 p.Ser945Leu
X
ABCC7 p.Ser945Leu 25033378:269:588
status: NEW
view ABCC7 p.Ser945Leu details
ABCC7 p.Asp1152His
X
ABCC7 p.Asp1152His 25033378:269:150
status: NEW
view ABCC7 p.Asp1152His details
ABCC7 p.Met952Ile
X
ABCC7 p.Met952Ile 25033378:269:356
status: NEW
view ABCC7 p.Met952Ile details
ABCC7 p.Phe1052Val
X
ABCC7 p.Phe1052Val 25033378:269:180
status: NEW
view ABCC7 p.Phe1052Val details
ABCC7 p.Phe508Cys
X
ABCC7 p.Phe508Cys 25033378:269:196
status: NEW
view ABCC7 p.Phe508Cys details
ABCC7 p.Arg668Cys
X
ABCC7 p.Arg668Cys 25033378:269:463
status: NEW
view ABCC7 p.Arg668Cys details
ABCC7 p.Gly576Ala
X
ABCC7 p.Gly576Ala 25033378:269:644
status: NEW
view ABCC7 p.Gly576Ala details
ABCC7 p.Arg31Cys
X
ABCC7 p.Arg31Cys 25033378:269:443
status: NEW
view ABCC7 p.Arg31Cys details
ABCC7 p.Asp443Tyr
X
ABCC7 p.Asp443Tyr 25033378:269:166
status: NEW
view ABCC7 p.Asp443Tyr details
ABCC7 p.Arg117Cys
X
ABCC7 p.Arg117Cys 25033378:269:408
status: NEW
view ABCC7 p.Arg117Cys details
ABCC7 p.Arg297Gln
X
ABCC7 p.Arg297Gln 25033378:269:436
status: NEW
view ABCC7 p.Arg297Gln details
ABCC7 p.Leu997Phe
X
ABCC7 p.Leu997Phe 25033378:269:337
status: NEW
view ABCC7 p.Leu997Phe details
ABCC7 p.Ile1027Thr
X
ABCC7 p.Ile1027Thr 25033378:269:622
status: NEW
view ABCC7 p.Ile1027Thr details
ABCC7 p.Arg1162Leu
X
ABCC7 p.Arg1162Leu 25033378:269:608
status: NEW
view ABCC7 p.Arg1162Leu details
ABCC7 p.Arg170His
X
ABCC7 p.Arg170His 25033378:269:422
status: NEW
view ABCC7 p.Arg170His details
ABCC7 p.Val201Met
X
ABCC7 p.Val201Met 25033378:269:526
status: NEW
view ABCC7 p.Val201Met details
ABCC7 p.Phe1074Leu
X
ABCC7 p.Phe1074Leu 25033378:269:188
status: NEW
view ABCC7 p.Phe1074Leu details
ABCC7 p.Ile336Lys
X
ABCC7 p.Ile336Lys 25033378:269:281
status: NEW
view ABCC7 p.Ile336Lys details
ABCC7 p.Leu967Ser
X
ABCC7 p.Leu967Ser 25033378:269:330
status: NEW
view ABCC7 p.Leu967Ser details
ABCC7 p.Gly1069Arg
X
ABCC7 p.Gly1069Arg 25033378:269:212
status: NEW
view ABCC7 p.Gly1069Arg details
ABCC7 p.Ser492Phe
X
ABCC7 p.Ser492Phe 25033378:269:581
status: NEW
view ABCC7 p.Ser492Phe details
ABCC7 p.Gly178Arg
X
ABCC7 p.Gly178Arg 25033378:269:236
status: NEW
view ABCC7 p.Gly178Arg details
ABCC7 p.Asp110His
X
ABCC7 p.Asp110His 25033378:269:143
status: NEW
view ABCC7 p.Asp110His details
ABCC7 p.Ser977Phe
X
ABCC7 p.Ser977Phe 25033378:269:505
status: NEW
view ABCC7 p.Ser977Phe details
ABCC7 p.Asp579Gly
X
ABCC7 p.Asp579Gly 25033378:269:173
status: NEW
view ABCC7 p.Asp579Gly details
ABCC7 p.Ile807Met
X
ABCC7 p.Ile807Met 25033378:269:299
status: NEW
view ABCC7 p.Ile807Met details
ABCC7 p.Arg74Gln
X
ABCC7 p.Arg74Gln 25033378:269:595
status: NEW
view ABCC7 p.Arg74Gln details
ABCC7 p.Ile1131Leu
X
ABCC7 p.Ile1131Leu 25033378:269:264
status: NEW
view ABCC7 p.Ile1131Leu details
ABCC7 p.Lys1180Thr
X
ABCC7 p.Lys1180Thr 25033378:269:314
status: NEW
view ABCC7 p.Lys1180Thr details
ABCC7 p.Ser485Arg
X
ABCC7 p.Ser485Arg 25033378:269:498
status: NEW
view ABCC7 p.Ser485Arg details
67 SNPs (125GtoC, 1716G.A, 1717-1G.A, 1898+1G.A, 2183AA.G, 2184delA, 2789+5G.A, 3120+1G.A, 3659delC, 3849+10kbC.T, 621+ 1G.T, 711+5G.A, A455E, D110H, D1152H, D1270N, D443Y, D579G, F1052V, F1074L, F508C, F508del, G1069R, G1244E, G1349D, G178R, G542X, G551D, G551S, I1131L/V, I148T, I336K/T, I507del, I807M, IVS8T5, K1180T, L1065P, L967S, L997F, M1V, M470V, M952I, M952T, N1303K, P67L, Q1463Q, R1070Q, R1162X, R117C, R117H, R170H, R258G, R297Q, R31C, R352Q, R553X, R668C, R74W, R75Q, S1235R, S1255P, S485R, S977F, T338I, T854T, V201M, W1282X) were multiplexed into 6 wells; 14 SNPs (S492F, S945L, R74Q, R560T, R1162L, G85E, I1027T, R334W, R347P, G576A, 711+1G.T, 1001+11C.T, P1290P, 3199del6) were ascertained separately via TaqMan Gene Expression Assays, with repeat confirmation of all positive results. Login to comment
270 ABCC7 p.Ile148Thr
X
ABCC7 p.Ile148Thr 25033378:270:74
status: NEW
view ABCC7 p.Ile148Thr details
3199del6 was genotyped via TaqMan on all samples that tested positive for I148T. Login to comment
309 ABCC7 p.Asp1152His
X
ABCC7 p.Asp1152His 25033378:309:86
status: NEW
view ABCC7 p.Asp1152His details
ABCC7 p.Leu997Phe
X
ABCC7 p.Leu997Phe 25033378:309:76
status: NEW
view ABCC7 p.Leu997Phe details
Using this model for WT CFTR, we generated in silico models for the mutants L997F and D1152H. Login to comment
356 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 25033378:356:13
status: NEW
view ABCC7 p.Arg117His details
*IVS8 T5 and R117H are reported but CF disease causing only when in cis with each other or IVS8 T5 with IVS8 TG12or13. Intronic mutations are reported in standard nomenclature ''####+/2##N.N`` except IVS8-T5, (1210-12T[5]). Login to comment